Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;23(45):1700797.
doi: 10.2807/1560-7917.ES.2018.23.45.1700797.

High rates of meticillin-resistant Staphylococcus aureus among asylum seekers and refugees admitted to Helsinki University Hospital, 2010 to 2017

Affiliations

High rates of meticillin-resistant Staphylococcus aureus among asylum seekers and refugees admitted to Helsinki University Hospital, 2010 to 2017

Tuomas Aro et al. Euro Surveill. 2018 Nov.

Abstract

IntroductionAntimicrobial resistance is increasing rapidly in countries with low hygiene levels and poorly controlled antimicrobial use. The spread of resistant bacteria poses a threat to healthcare worldwide. Refugees and migrants from high-prevalence countries may add to a rise in multidrug-resistant (MDR) bacteria in low-prevalence countries. However, respective data are scarce.MethodsWe retrospectively collected microbiological and clinical data from asylum seekers and refugees treated at Helsinki University Hospital between January 2010 and August 2017.ResultsOf 447 asylum seekers and refugees (Iraq: 46.5%; Afghanistan: 10.3%; Syria: 9.6%, Somalia: 6.9%); 45.0% were colonised by MDR bacteria: 32.9% had extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE), 21.3% meticillin-resistant Staphylococcus aureus (MRSA), 0.7% carbapenemase-producing Enterobacteriaceae (CPE), 0.4% multiresistant Pseudomonas aeruginosa (MRPA), 0.4% multiresistant Acinetobacter baumannii (MRAB); no vancomycin-resistant Enterococcus (VRE) were found. Two or more MDR bacteria strains were recorded for 12.5% of patients. Multivariable analysis revealed geographical region and prior surgery outside Nordic countries as risk factors of MRSA colonisation. Young age (< 6 years old), short time from arrival to first sample, and prior hospitalisation outside Nordic countries were risk factors of ESBL-PE colonisation.ConclusionWe found MDR bacterial colonisation to be common among asylum seekers and refugees arriving from current conflict zones. In particular we found a high prevalence of MRSA. Refugees and migrants should, therefore, be included among risk populations requiring MDR screening and infection control measures at hospitals.

Keywords: AMR; ESBL; Helsinki; MRSA; antimicrobial resistance; asylum seeker; multi-drug resistance; refugee.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: TA declares no conflicts of interest; AK has received honorary for lectures (Pfizer, MSD, Valneva, Immuron) and an investigator-initiated grant (Pfizer), and has on two occasions consulted an advisory board (Valneva), none of these relevant to the current manuscript.

Figures

Figure 1
Figure 1
Flowchart showing multidrug-resistant bacteria found in samples from asylum seekers and refugees admitted to Helsinki University Hospital, Finland, January 2010 to August 2017 (n = 447)
Figure 2
Figure 2
Rate of multidrug-resistant bacteria among asylum seekers and refugees admitted to Helsinki University Hospital, by country of origin or geographical region, Finland, January 2010 to August 2017 (n = 447)

References

    1. World Health Organization (WHO). Antimicrobial resistance: global report on surveillance. Geneva: WHO; 2014. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/
    1. World Health Organization (WHO). At UN, global leaders commit to act on antimicrobial resistance. Geneva: WHO; 2016. Available from: http://www.who.int/mediacentre/news/releases/2016/commitment-antimicrobi...
    1. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2006;50(4):1257-62. 10.1128/AAC.50.4.1257-1262.2006 - DOI - PMC - PubMed
    1. Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis. 2010;42(4):275-80. - PubMed
    1. Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564-8. 10.1128/AAC.00220-10 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances